Semaglutide-Induced Weight Loss Does Not Impair Muscle Function and Improves Endurance Running Capacity in Obese Mice.
BACKGROUND
Semaglutide, a member of the glucagon-like peptide-1 receptor agonists, induces substantial weight loss, primarily through appetite suppression and reduced energy intake. In addition to fat mass reduction, a considerable loss of lean body mass is also observed. How these effects...
